TVRD
Tvardi Therapeutics
TVRD
TVRD
180 hedge funds and large institutions have $368M invested in Tvardi Therapeutics in 2021 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 49 increasing their positions, 56 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
13% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 56
19% less capital invested
Capital invested by funds: $457M → $368M (-$89.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
180
Holding in Top 10
–
Calls
$5.9M
Puts
$3.2M
Top Buyers
| 1 | +$5.2M | |
| 2 | +$4.4M | |
| 3 | +$4.36M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$2.67M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.16M |
Top Sellers
| 1 | -$16M | |
| 2 | -$2.38M | |
| 3 | -$2.2M | |
| 4 |
Morgan Stanley
New York
|
-$1.16M |
| 5 |
Two Sigma Advisers
New York
|
-$1.05M |